Timothy T. Lu

6.3k citations

28 papers · 4.1k indexed · 3 hit papers · h-index 14

Impact in

Oncology top 1%
- Drug Transport and Resistance Mechanisms
Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism

Papers in

Cancer Research 10
- Cancer Genomics and Diagnostics 7
Genetics 10
- Inflammatory Bowel Disease 7

Co-authors: David J. Mangelsdorf Makoto Makishima Joyce J. Repa Thomas A. Kerr Johan Auwerx Kristina Schoonjans Wen Xie G. Kerr Whitfield
Journals: Gastroenterology (5 papers)Journal of Clinical Oncology (3 papers)Cancer Research (2 papers)Cancer Discovery (1 paper)Nature Medicine (1 paper)
Partner nations: United States Germany Denmark

In The Last Decade

Timothy T. Lu

28 papers receiving 4.0k citations

Hit Papers

align trajectories log scale

The role of IL-22 in intestinal health and disease 2020 · 306 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 The Journal of Experimental Medicine
2002 Science
2000 Molecular Cell

Peers

Countries citing papers authored by Timothy T. Lu

Since Specialization

Citations

This map shows the geographic impact of Timothy T. Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy T. Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy T. Lu more than expected).

Fields of papers citing papers by Timothy T. Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy T. Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy T. Lu. The network helps show where Timothy T. Lu may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy T. Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy T. Lu Line = papers co-authored together Timothy T. Lu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial Nature Medicine ·Martin Metz, Gordon Sussman, Rémi Gagnon, Petra Staubach, Tonny Tanus, William H. Yang, Jeremy J. Lim, Holly J. Clarke, Joshua Galanter, Leslie W. Chinn, Tom Chu, Anastasia Teterina, Tracy Burgess, D. James Haddon, Timothy T. Lu, Marcus Maurer	2021	94
2	Analytical validation of the Target Selector ctDNA platform featuring single copy detection sensitivity for clinically actionable EGFR, BRAF, and KRAS mutations PLoS ONE ·Jason C. Poole, 富之渡辺, Timothy T. Lu, Cecile Rose T. Vibat, 李秀娴, Errin Samuëlsz, Manisha Patel, Jeffrey Chen, Jordi Coca Armengou, Veena Singh, Lyle J. Arnold	2019	13
3	Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL‐22Fc): A Potential Therapy for Epithelial Injury Clinical Pharmacology & Therapeutics ·Michael E. Rothenberg, Yehong Wang, Annemarie Lekkerkerker, Dimitry M. Danilenko, Romeo Maciuca, Rich Erickson, Ann Herman, Eric Stefanich, Timothy T. Lu	2018	53
4	Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC Gut ·Jean‐Frédéric Colombel, Mary Keir, Alexis Scherl, Rui Zhao, Gert De Hertogh, William A. Faubion, Timothy T. Lu	2016	109
5	Detection of EGFR T790M Mutation in Urinary Circulating Tumor Dna From Metastatic Non-Small Cell Lung Cancer Patients Annals of Oncology ·Hatim Husain, Karena Kosco, Wu Jian, Timothy T. Lu, Cecile Rose T. Vibat, MG Erlander, Jefferson Mr	2015	5
6	Agreement Between Rectosigmoidoscopy and Colonoscopy Analyses of Disease Activity and Healing in Patients With Ulcerative Colitis Gastroenterology ·Jean‐Frédéric Colombel, Íngrid Ordás, Thomas Ullman, Paul Rutgeerts, Akiko Chai, Sharon O’Byrne, Timothy T. Lu, Julián Panés	2015	34
7	Rectal bleeding accurately reflects mucosal inflammation in patients with Ulcerative Colitis Mary Keir, Christopher R. Cabanski, Ren Zhao, J F Colombel, Julián Panés, Timothy T. Lu, Yuko NAGAI, Jack Μ. Fletcher, B G Feagan, Alexander Rueß, Peter Higgins, Gert De Hertogh, Gert Van Assche, John Mansfield, S Berrah, Paul Rutgeerts, Séverine Vermeire, 由利幸久	2015	1
8	The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis Nature Immunology ·Michio Onizawa, Shigeru Oshima, Ulf Schulze‐Topphoff, Juan A. Osés-Prieto, Timothy T. Lu, Rita M. Tavares, Thomas Prod’homme, Bao Duong, Michael I. Whang, Rommel Advincula, Alex Agelidis, Julio Barrera, Hao Wu, Alma L. Burlingame, Barbara A. Malynn, Scott S. Zamvil, Averil Ma	2015	229
9	Comparative circulating tumor DNA levels for KRAS mutations in patients with nonresectable pancreatic cancer. Journal of Clinical Oncology ·Julia S. Johansen, Cecile Rose T. Vibat, Dan Calatayud, Benny Vittrup Jensen, Jane Preuss Hasselby, Eric A. Collisson, Timothy T. Lu, Jason C. Poole, Mark G. Erlander	2015	2
10	Prognostic value of plasma circulating tumor (ct) DNA KRAS mutations and serum CA19-9 in unresectable pancreatic cancer (PC) patients. Journal of Clinical Oncology ·Julia S. Johansen, Cecile Rose T. Vibat, Saege Hancock, Inna M. Chen, 黄佩刚, Errin Samuëlsz, Eric A. Collisson, Benny Vittrup Jensen, Timothy T. Lu, Demetria Powell, Mark G. Erlander	2015	2
11	Highly sensitive quantitative detection of circulating tumor DNA in urine and plasma from advanced colorectal cancer patients in aid of early diagnosis of clinically relevant KRAS mutations. Journal of Clinical Oncology ·Jason C. Poole, Cecile Rose T. Vibat, Lucie Benešová, Barbora Belšánová, Saege Hancock, Timothy T. Lu, Mark G. Erlander, Marek Minárik	2015	2
12	Su1220 Rectal Bleeding Accurately Reflects Level of Mucosal Inflammation in Patients With Ulcerative Colitis Gastroenterology ·Sharon O’Byrne, Mary Keir, Christopher R. Cabanski, Rui Zhao, Jean–Frédéric Colombel, Julián Panés, Timothy T. Lu, William A. Faubion, Joel G. Fletcher, Brian G. Feagan, 覚貴田, Peter Higgins, Gert De Hertogh, Gert A. Van Assche, John Mansfield, William J. Sandborn, Paul Rutgeerts, Séverine Vermeire	2015	2
13	Prospective Blinded Study of BRAF V600E Mutation Detection in Cell-Free DNA of Patients with Systemic Histiocytic Disorders Cancer Discovery ·David M. Hyman, Eli L. Diamond, Cecile Rose T. Vibat, 黄佩刚, Jason C. Poole, Minal Patel, Veronica R. Holley, Goran Cabrilo, Timothy T. Lu, Maria E. Arcila, Young Rock Chung, Raajit K. Rampal, Mario E. Lacouture, Neal Rosen, Funda Meric‐Bernstam, José Baselga, Razelle Kurzrock, Mark G. Erlander, Filip Jankú, Omar Abdel‐Wahab	2014	84
14	Dimerization and Ubiquitin Mediated Recruitment of A20, a Complex Deubiquitinating Enzyme Immunity ·Timothy T. Lu, Michio Onizawa, Gianna Hammer, Emre E. Turer, Qian Yin, Morris Rl, Alex Agelidis, Nataliya Tovbis Shifrin, Rommel Advincula, Julio Barrera, Barbara A. Malynn, Hao Wu, Averil Ma	2013	117
15	Genomic and geographic distribution of SNP-defined runs of homozygosity in Europeans Human Molecular Genetics ·Michael Nothnagel, Timothy T. Lu, Manfred Kayser, Michael Krawczak	2010	125
16	Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus Nature Genetics ·Stacy L. Musone, Kimberly E. Taylor, Timothy T. Lu, Joanne Nititham, Ricardo C. Ferreira, Ward Ortmann, Nataliya Tovbis Shifrin, Michelle Petri, M. Ilyas Kamboh, Susan Manzi, Michael F. Seldin, Peter K. Gregersen, Timothy W. Behrens, Averil Ma, Pui–Yan Kwok, Lindsey A. Criswell	2008	332
17	Patterns of linkage disequilibrium in the MHC region on human chromosome 6p Human Genetics ·Oliver Walker, Timothy T. Lu, Werner Koch, Jochen Hampe, R. Laumer, Francisco M. De La Vega, Michael Krawczak, Stefan Schreiber	2004	80
18	Vitamin D Receptor As an Intestinal Bile Acid Sensor Science ·Makoto Makishima, Timothy T. Lu, Wen Xie, G. Kerr Whitfield, Hideharu Domoto, Ronald M. Evans, Mark R. Haussler, David J. Mangelsdorf Hit paper breakdown →	2002	918
19	Orphan Nuclear Receptors as eLiXiRs and FiXeRs of Sterol Metabolism Journal of Biological Chemistry ·Timothy T. Lu, Joyce J. Repa, David J. Mangelsdorf	2001	300
20	Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors Molecular Cell ·Timothy T. Lu, Makoto Makishima, Joyce J. Repa, Kristina Schoonjans, Thomas A. Kerr, Johan Auwerx, David J. Mangelsdorf Hit paper breakdown →	2000	1247

About Timothy T. Lu

Timothy T. Lu is a scholar working on Cancer Research, Genetics, Immunology, Pathology and Forensic Medicine and Oncology, having authored 28 papers that have together received 4.1k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (7 papers), Cancer Genomics and Diagnostics (7 papers), Diverticular Disease and Complications (5 papers), interferon and immune responses (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Molecular Biology Techniques and Applications (3 papers), Cholesterol and Lipid Metabolism (3 papers) and Microscopic Colitis (3 papers). The work is most often cited by research in Oncology (1.7k citations), Pharmacology (332 citations), Immunology (804 citations), Cancer Research (474 citations) and Surgery (1.3k citations). Timothy T. Lu has collaborated with scholars based in United States, Germany and Denmark. Frequent co-authors include David J. Mangelsdorf, Makoto Makishima, Joyce J. Repa, Thomas A. Kerr, Johan Auwerx, Kristina Schoonjans, Wen Xie, G. Kerr Whitfield, Mark R. Haussler and Hideharu Domoto. Their work appears in journals such as Gastroenterology, Journal of Clinical Oncology, Cancer Research, Cancer Discovery and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact